The upregulation of MCM6 was found to have a strong correlation with leukaemia, breast cancer, male‐specific cancers, skin cancer and head and neck cancer, while also demonstrating a significant association with lactose intolerance and some symptom (Figure S1C). Here, MCM6 is linked to skin cancer.